From: Epidemiology of canine mammary tumours on the Canary Archipelago in Spain
Histological type | Proportion (CI95%) | Trend test p-value* |
---|---|---|
Complex carcinoma | 42.30% (40.52%; 44.10%) | 0.2150 |
Tubulopapillary carcinoma | 29.74% (28.10%; 31.42%) | 0.9030 |
Carcinoma in benign tumour | 15.70% (14.40%; 17.05%) | 0.3190 |
Solid carcinoma | 5.42% (4.64%; 6.30%) | 0.8990 |
Carcinosarcoma | 2.22% (1.72%; 2.82%) | 0.4360 |
Carcinoma NOSa | 1.01% (0.68%; 1.44%) | 0.2250 |
Anaplastic carcinoma | 0.94% (0.63%; 1.36%) | 0.3230 |
In situ carcinoma | 0.94% (0.63%; 1.36%) | < 0.0001 |
Squamous cell carcinoma | 0.74% (0.46%; 1.12%) | 0.0133 |
Osteosarcoma | 0.37% (0.19%; 0.66%) | 0.5560 |
Fibrosarcoma | 0.20% (0.07%; 0.44%) | 0.0879 |
Haemangiosarcoma | 0.17% (0.05%; 0.39%) | 0.4260 |
Lipid-rich carcinoma | 0.13% (0.04%; 0.34%) | 0.7220 |
Cribriform carcinoma | 0.03% (0.00%; 0.19%) | 0.4760 |
Osteochondrosarcoma | 0.03% (0.00%; 0.19%) | 0.1300 |
Spindle cell carcinoma | 0.03% (0.00%; 0.19%) | 0.7890 |